Current Location:HomeCMC ProcessCell Line Development
HaoYue Fut8 Knockout Cell Line Platforms is developed from commercially licensable CHO-K1 host cells. This platform enables the generation of homogeneous and stable low-fucosylation modified cell lines through transfection and screening, resulting in enhanced ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) effects.
Email:healsunbd@hs-biopharm.com
Copyright © 2023 杭州皓阳生物技术有限公司All Rights Reserved 浙ICP备16013229号-1 浙公网安备 33011002011493号 技术支持:杭州网站制作